$MIRM Cashflow Statement | Understand Stock

$MIRM

$85.56 +$2.29 (2.75%) Close

$MIRM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net loss
Reconciliation of net loss to net cash provided by operating activities:
Stock-based compensation
Depreciation and amortization
Inventory reserves and firm commitment losses
Amortization of debt discount and offering costs
Change in fair value of derivative liability
Change in fair value of contingent liabilities associated with acquisition
Loss from termination of revenue interest purchase agreement
Costs recognized on sale of acquired inventory
Non-cash interest expense related to the revenue interest liability
Deferred income taxes associated with an acquisition
Gain on sale of priority review voucher, net
Unrealized foreign exchange (gain) loss
Non-cash lease expense
Net accretion of discounts on investments
Other
Change in operating assets and liabilities:
Accounts receivable
Prepaid and other current assets
Operating lease right-of-use assets
Inventory
Other assets
Accounts payable, accrued expenses and other liabilities
Operating lease liabilities

Net cash provided by (used in) operating activities
Investing activities
Purchase of investments
Proceeds from maturities of investments
Proceeds from paydown of investments
Purchase of property and equipment
Cash paid for acquisition
Payments made for additions to intangible assets
Proceeds from sale of priority review voucher, net
Net cash used in investing activities
Financing activities
Proceeds from issuance of common stock in private placement, net of issuance costs
Proceeds from issuance of common stock in at-the-market offerings, net of issuance costs
Proceeds from issuance of common stock in public offerings, net of issuance costs
Proceeds from issuance of convertible notes, net
Proceeds from issuance of common stock pursuant to equity plans
Payments of deferred offering costs
Payments on revenue interest liability
Proceeds from revenue interest liability, net of issuance costs
Net cash provided by financing activities
Effect of exchange rate on cash, cash equivalents and restricted cash
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Supplemental disclosure of cash flow information:
Operating cash flows paid for operating lease
Cash paid for interest
Cash paid for income taxes
Non-cash operating, investing and financing activities:
Revenue interest liability issuance costs included in accrued liabilities
Deferred offering costs included in accrued liabilities
Compound derivative liability related to revenue interest liability
Inventory purchases included in accrued liabilities
Accrued milestone payments classified as intangible assets, net
Right-of-use assets obtained in exchange for lease liabilities
Decrease in ROU assets and lease liabilities due to lease modification
Stock-based compensation capitalized to inventory
Conversion of convertible notes, net into shares of common stock
Issuance of common stock in connection with settlement of Contingent Milestone and Indemnification Holdback liabilities
Contingent Milestone and Indemnification Holdback liabilities for common stock issuance in exchange for acquired intangible assets
Issuance of common stock in exchange for acquired intangible
Deferred tax liability incurred from acquired intangible
Contingent milestone liability for common stock issuance for acquired intangible assets
Indemnification Holdback liability for common stock issuance in exchange for acquired intangible assets

Comments